TrialScope Overview

  • Founded
  • 2012
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 44
Employees
  • Latest Deal Type
  • M&A

TrialScope General Information

Description

Developer of a clinical trial management platform designed to simplify the complexities of clinical trial transparency. The company's platform provides tools to comply with legislation and internal policy, to register clinical trials, disclose results and also allows knowledge sharing and collaboration, enabling clinical trial sponsors to manage the growing risk, complexity, and costs associated with clinical trial disclosure while improving performance, and ultimately optimize efficiencies.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare Services
Consulting Services (B2B)
Parent Company
Informa
Primary Office
  • 185 Hudson Street
  • Suite 2900
  • Jersey City, NJ 07311
  • United States
+1 (877) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TrialScope Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Jan-2020 000.00 Completed Generating Revenue
6. Secondary Transaction - Private 000.00 Completed Generating Revenue
5. Later Stage VC (Series C) 17-Sep-2018 000 000.00 0000 Completed Generating Revenue
4. Early Stage VC (Series B) 25-Apr-2017 00.000 000.00 000.00 Completed Generating Revenue
3. Debt - General 02-Feb-2015 000 000.00 Completed Generating Revenue
2. Early Stage VC (Series A1) 04-Jun-2014 $10.2M $12.8M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 12-Dec-2013 $2.56M $2.56M 00.000 Completed Generating Revenue
To view TrialScope’s complete valuation and funding history, request access »

TrialScope Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 9,651,596 $0.000100 8% $1.06 $1.06 1x $1.06 37.82%
Series A 2,425,112 $0.000100 8% $1.06 $1.06 1x $1.06 9.5%
To view TrialScope’s complete cap table history, request access »

TrialScope Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a clinical trial management platform designed to simplify the complexities of clinical trial transparency.
Other Healthcare Technology Systems
Jersey City, NJ
44 As of 2021
000.00
000000&0 000.00

0000000

t, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
00000 0000000000 00000000
San Jose, CA
00 As of 0000
00.00
000 0000-00-00
000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TrialScope Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000 Venture Capital-Backed San Jose, CA 00 00.00 000000000 00.00
You’re viewing 1 of 1 competitors. Get the full list »

TrialScope Executive Team (21)

Name Title Board Seat Contact Info
Jeffrey Kozloff Chief Executive Officer & Board Member
Matthew Patras Chief Financial Officer
David Laky Chief Operating Officer
Thomas Wicks Chief Strategy Officer
Naor Chazan Chief Marketing Officer
You’re viewing 5 of 21 executive team members. Get the full list »

TrialScope Board Members (14)

Name Representing Role Since
Christopher Noe Dublin Capital Partners Board Member 000 0000
James Walker Self Board Member 000 0000
Jeffrey Kozloff TrialScope Chief Executive Officer & Board Member 000 0000
Marc Lederman NewSpring Capital Board Member 000 0000
Michael Balmuth Edison Partners Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

TrialScope Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TrialScope Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Dublin Capital Partners Venture Capital Minority 000 0000 000000 0
Edison Partners Venture Capital Minority 000 0000 000000 0
NewSpring Capital Growth/Expansion Minority 000 0000 000000 0
To view TrialScope’s complete investors history, request access »

TrialScope Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 22-Oct-2019 0000000000 Other Healthcare Technology Systems 0000000 0
Deloitte Analytics 03-Jun-2014 Merger/Acquisition Systems and Information Management 0000000 0
To view TrialScope’s complete acquisitions history, request access »

TrialScope Subsidiaries (1)

Company Name Industry Location Founded
00000000 00000 000 Other Healthcare Technology Systems New York, NY 0000
To view TrialScope’s complete subsidiaries history, request access »